Krause A - Search Results

1

Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors.

Miller WR, Larionov A, Anderson TJ, Walker JR, Krause A, Evans DB, Dixon JM. Miller WR, et al. Among authors: krause a. Cancer. 2008 Feb 1;112(3 Suppl):689-694. doi: 10.1002/cncr.23187. Cancer. 2008. PMID: 18072233 Free article.

2

An integrated view of aromatase and its inhibition.

Miller WR, Anderson TJ, Evans DB, Krause A, Hampton G, Dixon JM. Miller WR, et al. Among authors: krause a. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):413-21. doi: 10.1016/s0960-0760(03)00352-2. J Steroid Biochem Mol Biol. 2003. PMID: 14623539 Review.

3

Aromatase inhibitors: cellular and molecular effects.

Miller WR, Anderson TJ, White S, Larionov A, Murray J, Evans D, Krause A, Dixon JM. Miller WR, et al. Among authors: krause a. J Steroid Biochem Mol Biol. 2005 May;95(1-5):83-9. doi: 10.1016/j.jsbmb.2005.04.010. J Steroid Biochem Mol Biol. 2005. PMID: 16002280

4

Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience.

Miller WR, Anderson TJ, White S, Evans D, Krause A, Dixon JM. Miller WR, et al. Among authors: krause a. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S119-23. doi: 10.1677/erc.1.00995. Endocr Relat Cancer. 2005. PMID: 16113088 Review.

5

Aromatase inhibitors--gene discovery.

Miller WR, Larionov A, Renshaw L, Anderson TJ, White S, Hampton G, Walker JR, Ho S, Krause A, Evans DB, Dixon JM. Miller WR, et al. Among authors: krause a. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):130-42. doi: 10.1016/j.jsbmb.2007.05.013. Epub 2007 May 29. J Steroid Biochem Mol Biol. 2007. PMID: 17616392

6

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole.

Miller WR, Larionov AA, Renshaw L, Anderson TJ, White S, Murray J, Murray E, Hampton G, Walker JR, Ho S, Krause A, Evans DB, Dixon JM. Miller WR, et al. Among authors: krause a. Pharmacogenet Genomics. 2007 Oct;17(10):813-26. doi: 10.1097/FPC.0b013e32820b853a. Pharmacogenet Genomics. 2007. PMID: 17885619 Clinical Trial.

7

Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.

Miller WR, Larionov A, Renshaw L, Anderson TJ, Walker JR, Krause A, Sing T, Evans DB, Dixon JM. Miller WR, et al. Among authors: krause a. J Clin Oncol. 2009 Mar 20;27(9):1382-7. doi: 10.1200/JCO.2008.16.8849. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224856

8

Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies.

Scherer A, Krause A, Walker JR, Korn A, Niese D, Raulf F. Scherer A, et al. Among authors: krause a. Transplantation. 2003 Apr 27;75(8):1323-30. doi: 10.1097/01.TP.0000068481.98801.10. Transplantation. 2003. PMID: 12717224 Clinical Trial.

9

A standard curve based method for relative real time PCR data processing.

Larionov A, Krause A, Miller W. Larionov A, et al. Among authors: krause a. BMC Bioinformatics. 2005 Mar 21;6:62. doi: 10.1186/1471-2105-6-62. BMC Bioinformatics. 2005. PMID: 15780134 Free PMC article.

10

Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole.

Ellis MJ, Tao Y, Young O, White S, Proia AD, Murray J, Renshaw L, Faratian D, Thomas J, Dowsett M, Krause A, Evans DB, Miller WR, Dixon JM. Ellis MJ, et al. Among authors: krause a. J Clin Oncol. 2006 Jul 1;24(19):3019-25. doi: 10.1200/JCO.2005.04.3034. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,058 results

Search Page

Filters